Not applicableStudy completedNCT00363012
What this trial is testing
Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2
Who this might be right for
Breast Cancer
University of Washington 56